Surgery Partners (NASDAQ: SGRY) net income
Surgery Partners reported a net loss of $77.9m for fiscal 2025; in fiscal 2024 it reported a net loss of $168.1m. Earnings per share were −$0.61.
Surgery Partners's best year of the last 10 was fiscal 2016. It reported a loss in 8 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$77.9m | — | −2.4% | −$0.61 |
| 2024 | −$168.1m | — | −5.4% | −$1.33 |
| 2023 | −$11.9m | — | −0.4% | −$0.09 |
| 2022 | −$54.6m | — | −2.2% | −$0.59 |
| 2021 | −$70.9m | — | −3.2% | −$1.12 |
| 2020 | −$116.1m | — | −6.2% | −$3.19 |
| 2019 | −$74.8m | — | −4.1% | −$2.29 |
| 2018 | −$205.7m | — | −11.6% | −$4.96 |
| 2016 | $9.5m | +561.5% | 0.8% | $0.20 |
| 2015 | $1.4m | — | 0.1% | $0.04 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Surgery Partners net income compared with its sector
By net income for its latest fiscal year, Surgery Partners ranks 308th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Surgery Partners, −2.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 306th | Rezolute | −$77.6m | — |
| 307th | Twist Bioscience | −$77.7m | −20.6% |
| 308th | Surgery Partners | −$77.9m | −2.4% |
| 309th | Avalo Therapeutics | −$78.3m | −132,642.4% |
| 310th | Corbus Pharmaceuticals | −$78.5m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Surgery Partners
- How much did Surgery Partners earn in fiscal 2025?
- Surgery Partners reported a net loss of $77.9m for fiscal 2025. In fiscal 2024 it reported a net loss of $168.1m.
- What are the earnings per share of Surgery Partners?
- They were −$0.61 in fiscal 2025, compared with −$1.33 in fiscal 2024.
- What was the most profitable year for Surgery Partners?
- Of its last 10 fiscal years, fiscal 2016, with $9.5m.
- Where does Surgery Partners rank in its sector by net income?
- It ranks 308th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Surgery Partners come from?
- From the annual report (Form 10-K) that Surgery Partners files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Surgery Partners files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2016 · 2015. More on Surgery Partners: the Surgery Partners page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.